Five-Year Financial Summary

In millions, except per share amounts 2015 2014 2013 2012 2011
Statement of operations data:          
Net revenues $ 153,290 $ 139,367 $ 126,761 $ 123,120 $ 107,080
Gross profit 26,528 25,367 23,783 22,488 20,562
Operating expenses(1) 17,074 16,568 15,746 15,278 14,231
Operating profit 9,454 8,799 8,037 7,210 6,331
Interest expense, net 838 600 509 557 584
Loss on early extinguishment of debt 521 348
Income tax provision(2) 3,386 3,033 2,928 2,436 2,258
Income from continuing operations 5,230 4,645 4,600 3,869 3,489
Income (loss) from discontinued operations, net of tax 9 (1) (8) (7) (31)
Net income 5,239 4,644 4,592 3,862 3,458
Net loss attributable to noncontrolling interest (2) 2 4
Net income attributable to CVS Health $ 5,237 $ 4,644 $ 4,592 $ 3,864 $ 3,462
Per common share data:          
Basic earnings per common share:          
Income from continuing operations attributable to CVS Health $ 4.65 $ 3.98 $ 3.78 $ 3.05 $ 2.61
Loss from discontinued operations attributable to CVS Health $ 0.01 $ 0.00 $ (0.01) $ (0.01) $ (0.02)
Net income attributable to CVS Health $ 4.66 $ 3.98 $ 3.77 $ 3.04 $ 2.59
Diluted earnings per common share:          
Income from continuing operations attributable to CVS Health $ 4.62 $ 3.96 $ 3.75 $ 3.02 $ 2.59
Loss from discontinued operations attributable to CVS Health $ 0.01 $ 0.00 $ (0.01) $ (0.01) $ (0.02)
Net income attributable to CVS Health $ 4.63 $ 3.96 $ 3.74 $ 3.02 $ 2.57
Cash dividends per common share $ 1.40 $ 1.10 $ 0.90 $ 0.65 $ 0.50
Balance sheet and other data:          
Total assets $ 93,657 $ 74,187 $ 71,452 $ 66,167 $ 64,794
Long-term debt $ 26,267 $ 11,630 $ 12,767 $ 9,079 $ 9,150
Total shareholders’ equity $ 37,203 $ 37,963 $ 37,938 $ 37,653 $ 38,014
Number of stores (at end of year) 9,681 7,866 7,702 7,508 7,388

(1) Operating expenses include a $72 million gain on a legal settlement duing the year ended December 31, 2013.

(2) Income tax provision for the year ended December 31, 2010, includes the effect of the recognition of $47 million of previously unrecognized tax benefits, including interest, relating to the expiration of various statutes of limitation and settlements with tax authorities.

(3) As of June 30, 2015, the Company early adopted Accounting Standard Update No. 2015-03, Simplifying the Presentation of Debt Issuance Costs (Topic 835-30) issued by the Financial Accounting Standards Board in April 2015. The effect of the adoption on the Company's consolidated balance sheet is a reduction in noncurrent assets and long-term debt of $65 million, $74 million, $54 million and $58 million as of December 31, 2014, 2013, 2012 and 2011, respectively.